Welcome To The Breathe Initiative
Healthcare providers have an important role in addressing the highly individualized needs of their patients with severe asthma. As part of the management process, healthcare providers must be fully engaged in all of their patients’ treatment plans. By encouraging patients to take an active role in the management of their severe asthma symptoms and treatments by participating in the development of an asthma action plan, they can empower patients to take control of their health and attain the best possible outcomes.
The patient has an important role in the management of their severe asthma symptoms and treatments. Patients must understand and follow their asthma action plan–and tailor it as needed–in collaboration with their providers to be up to date on asthma attack information. This page includes information on the frequency and management of severe asthma with asthma inhalers and asthma attack information to help empower you, the patient, to take control of your health.
Clinical Toolkit
Healthcare providers have an important role in addressing the highly individualized needs of their patients with severe asthma. As part of the management process, healthcare providers must be fully engaged in all of their patients’ treatment plans. By encouraging patients to take an active role in the management of their severe asthma symptoms and treatments by participating in the development of an asthma action plan, they can empower patients to take control of their health and attain the best possible outcomes.
Patient Toolkit
The patient has an important role in the management of their severe asthma symptoms and treatments. Patients must understand and follow their asthma action plan–and tailor it as needed–in collaboration with their providers to be up to date on asthma attack information. This page includes information on the frequency and management of severe asthma with asthma inhalers and asthma attack information to help empower you, the patient, to take control of your health.
The BREATHE Initiative
Asthma affects more than 25 million people in the United States and 339 million people around the world.1,2, it is in fact a heterogeneous disease with varying levels of burden.3 Severe asthma affects approximately 5% to 10% of patients with asthma.4 In these patients it is especially crucial for clinicians to be aware of the importance of having an effective asthma action plan and to recognize the importance of implementing best practices for severe asthma control.
To effectively manage severe asthma, clinicians must appreciate the clinical phenotypes associated with severe asthma, the specific molecular pathways involved in severe asthma, and the integration of molecularly targeted biological therapies for effective and safe patient management. Through an appreciation of the heterogeneity of severe asthma and the properties of specific therapies for the management of severe asthma, clinicians can implement up-to-date strategies to optimize patient care and educate patients on asthma symptoms and treatments. This site serves to provide clinicians with information to help personalize the care of patients with severe asthma and to help clinicians find ways for patients to navigate the dynamic field of personalized care for severe asthma.